Editorial
Copyright ©2010 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Oct 7, 2010; 16(37): 4634-4639
Published online Oct 7, 2010. doi: 10.3748/wjg.v16.i37.4634
Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinoma
Tsutomu Namikawa, Kazuhiro Hanazaki
Tsutomu Namikawa, Kazuhiro Hanazaki, Department of Surgery, Kochi Medical School, Kohasu-Okocho, Nankoku-City, Kochi 783-8505, Japan
Author contributions: Namikawa T drafted the manuscript; Hanazaki K carried out critical revision.
Correspondence to: Kazuhiro Hanazaki, Professor, Department of Surgery, Kochi Medical School, Kohasu-Okocho, Nankoku-City, Kochi 783-8505, Japan. hanazaki@kochi-u.ac.jp
Telephone: +81-88-8802370 Fax: +81-88-8802371
Received: March 16, 2010
Revised: April 7, 2010
Accepted: April 14, 2010
Published online: October 7, 2010
Abstract

Differentiated adenocarcinoma of the stomach is classified into gastric or intestinal phenotypes based on mucus expression. Recent advances in mucin histochemistry and immunohistochemistry have highlighted the importance of such a distinction, and it is important clinically to distinguish between gastric- and intestinal-type differentiated adenocarcinoma. However, a clinical and pathological diagnosis of this type is often difficult in early gastric cancer because of histological similarities between a hyperplastic epithelium and low-grade atypia. Furthermore, determining tumor margins is often difficult, even with extensive preoperative examination. It is therefore critical to consider these diagnostic difficulties and different biological behaviors with high malignant potential when treating patients with gastric-type differentiated adenocarcinoma.

Keywords: Differentiated adenocarcinoma; Gastric cancer; Gastric phenotype; Mucin core protein; Mucous phenotype